9.15
price down icon3.07%   -0.29
 
loading

Viatris Inc 주식(VTRS)의 최신 뉴스

pulisher
Mar 21, 2025

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Mar 21, 2025
pulisher
Mar 21, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisVTRS - Markets Insider

Mar 21, 2025
pulisher
Mar 21, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateVTRS - ACCESS Newswire

Mar 20, 2025
pulisher
Mar 18, 2025

VTRS Investigation: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire

Mar 18, 2025
pulisher
Mar 17, 2025

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now? - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

Opus, Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug - Bloomberg Law

Mar 17, 2025
pulisher
Mar 16, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are ... - The Bakersfield Californian

Mar 16, 2025
pulisher
Mar 16, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.

Mar 16, 2025
pulisher
Mar 16, 2025

Viatris Inc. Under Investor Scrutiny: Levi & Korsinsky Launches Securities Investigation - Apna Kal

Mar 16, 2025
pulisher
Mar 15, 2025

Viatris Stock Plummets Over 15% Amid Earnings Miss and FDA Warning – Investors Encouraged to Take Action - Apna Kal

Mar 15, 2025
pulisher
Mar 14, 2025

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation – VTRS - Bluefield Daily Telegraph

Mar 14, 2025
pulisher
Mar 14, 2025

Viatris Inc (VTRS) Volatility Hits 3.27% – Here Is What You Should Do - Stocks Register

Mar 14, 2025
pulisher
Mar 14, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Viatris Inc. (VTRS) And Encourages Shareholders to Reach Out - Markets Insider

Mar 14, 2025
pulisher
Mar 13, 2025

Investors who Lost Money on Viatris Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationVTRS - ACCESS Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Viatris Inc. (VTRS) and Encourages Shareholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

Viatris Inc. (VTRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris Inc. (VTRS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris’s SWOT analysis: generic drug maker’s stock faces headwinds - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Viatris’s SWOT analysis: generic drug maker’s stock faces headwinds By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Viatris Inc. (VTRS) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Viatris at Barclays Conference: Strategic Moves Amid Challenges - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Securities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire

Mar 11, 2025
pulisher
Mar 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc.VTRS - PR Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Viatris Inc. (VTRS) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 10, 2025

ATTENTION Viatris Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 10, 2025

Viatris Inc. (VTRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 10, 2025
pulisher
Mar 09, 2025

Why Viatris Inc. (VTRS) Is Plunging So Far In 2025 - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Viatris Inc. (VTRS) And Encourages Investors to Connect - Markets Insider

Mar 09, 2025
pulisher
Mar 07, 2025

Viatris price target lowered to $13 from $15 at Jefferies - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

LEXICON PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Jefferies cuts Viatris stock price target to $13, maintains Buy - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Jefferies Adjusts Viatris Price Target to $13 From $15, Maintains Buy Rating -March 07, 2025 at 12:10 pm EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Viatris Inc. (VTRS) Stockholders to Inquire about Securities Investigation - Markets Insider

Mar 07, 2025
pulisher
Mar 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Viatris Inc. (VTRS) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 06, 2025
pulisher
Mar 06, 2025

ATTENTION VTRS SHAREHOLDERS: Investors who lost money on Viatris Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

Viatris to Present at the Barclays 27th Annual Global Healthcare Conference - PR Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Viatris stock target cut to $10 by Piper Sandler, maintains neutral - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Forecasting The Future: 4 Analyst Projections For Viatris - Benzinga

Mar 05, 2025
pulisher
Mar 05, 2025

Viatris price target lowered to $10 from $14 at Piper Sandler - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Viatris Inc. Being Investigated on Behalf of Viatris Inc. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler Adjusts Price Target on Viatris to $10 From $14, Maintains Neutral Rating - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Analyst recommendations: Applovin, Palantir, T-Mobile US, Constellation Brands, Viatris… - Marketscreener.com

Mar 05, 2025
pulisher
Mar 04, 2025

Wall Street Wary as Viatris (VTRS) Dives into Generic Weight Loss Drug Market - Markets Insider

Mar 04, 2025
pulisher
Mar 04, 2025

Viatris outlines $450M-$550M product revenue target for 2025 while addressing Indore impact - MSN

Mar 04, 2025
$111.92
price up icon 1.68%
$131.65
price up icon 0.04%
$97.71
price down icon 1.15%
$34.60
price up icon 2.00%
$10.53
price down icon 0.47%
자본화:     |  볼륨(24시간):